Kampala Key, Vulnerable and Priority Populations (KVP) News

Landmark PrEP Study Seeks Black Men Who Have Sex With Men Researchers at universities in three different states will  participate  in the study. The  HIV Prevention Trials Network  has begun the process of screening men for possible involvement in what may be a landmark study. The study, known as HPTN 073, will be studying pre-exposure prophylaxis initiation and adherence in HIV-negative black men who have sex with men. The study will occur at three of the network’s United States research facilities in Washington, D.C.; Chapel Hill, North Carolina; and Los Angeles. Those involved in the study will participate through colleges  near the research facilities: George Washington University, University of North Carolina, and University of California, Los Angeles. For more information tune into a live Twitter chat will be hosted on Wednesday, August 14 at 1p.m. EST on the  HIV Prevention  Trials Network’s page,  @HIVptn , featuring the hashtag...

Scientists Gets $1.4 Million to Search for an HIV Cure The grants, given by amFAR, are among the largest in the country. The Foundations for AIDS Research  has announced a new round of grants totaling more than $1.4 million that will be given through its program, amFAR Research Consortium on HIV Eradication (ARCHE) to four separate teams of scientists who are breaking ground in new research. The scientists work at the leading institutions around the world and, with proper funding, are getting closer than ever finding a cure for HIV and AIDS. “Through ARCHE, amfAR leverages the expertise  and innovation  of distinguished scientists from across the globe to advance cure-focused research,” amfAR CEO Kevin Robert Frost  said in a statement . “Some of the most important recent advances in HIV research are the result of strategic collaborations among amfAR-funded scientists and are a testament to the success of our cooperative approach to research.” AmFar last r...

Why I'm Taking PrEP — and Maybe You Should Too Coming out as an HIV-negative, sexually active gay man on PReP. A month ago, I began taking a blue pill each day, called Truvada. It's a combination of two of the three antiretroviral medications that form the cocktail used to treat people with HIV. Last year, the FDA approved the prescription of Truvada for the preventing of HIV in people who are uninfected. The term for this is pre-exposure prophylaxis (PrEP). I'm HIV negative. My choice to begin taking a highly-potent  HIV drug  wasn't an easy one. And the decision to come out publicly as someone who's on PrEP is not one that I take lightly. But the more I learn about PrEP, the more shocked I'm becoming that gay men are not shouting from the rooftops about this potential game changer in the fight to prevent new HIV infections, which we're losing badly. I'm ready to shout about it. Here's what helped convince me: Dr. Robert Grant of UCSF, the r...

What Will NYC's Next Mayor Do About HIV? Gay Men's Health Crisis hosts all the major mayoral candidates and releases comprehensive  survey  on their opinions about HIV and AIDS. GMHC  hosted a mayoral candidates forum in New York City on July 23 to bring to light candidates positions on issues ranging from healthcare to youth homelessness as they relate to the HIV epidemic. The unpredented forum, the first of its kind to ask major political candidates weigh in on issues around HIV, AIDS, and LGBT health, featured six of the 12 candidates who are qualified to appear on the primary ballot. It moderated by Oriol Gutierrez, the editor-in-chief of  POZ Magazine . The  2013 Mayoral Candidate Survey Report  was released the same week, detailing positions from five of the mayoral candidates: former city councilmember Sal Albanese, New York City comptroller John Liu, city council speaker Christine Quinn, former city comptroller Bill Thompson, and former...

KATHMANDU, 31 July 2013 (IRIN) - Despite years of scientific advances in  HIV treatment  and prevention, more than two million people are newly diagnosed with HIV annually, demonstrating how community-driven approaches to prevention are still needed to curb the epidemic, experts say. For years evidence has mounted that anti-retroviral therapy (ART) - virus-suppressing drug combinations that are the primary  treatment for HIV  - can also be used effectively in  prevention . However due to the complications associated with ART procurement, distribution, uptake, adherence, and potential behaviour change in patients (some studies have linked increased risk-taking behaviours in HIV patients post-treatment), a fresh local approach to implementing ART-based prevention programmes is needed, new research argues. “Research in  HIV prevention  needs to get out beyond its comfort zone and meet with the people who have very different ideas about what HIV means,”...

Monthly injections have shown to be safer than a daily tablet for men who are taking PrEP to prevent  HIV infection . Johnson and Johnson and GlaxoSmithKline may have come up with an even more convenient way of  treating HIV  — not with daily tablets but with new monthly injections that at least one study suggests might be even safer. Though it seems like most patients would prefer pills over needles, a new  survey published  in Nanomedicine  has shown that 84% of HIV-positive people would rather have monthly injections. The side effects of injection (versus the newer, popular daily tablets) may be less as well, according to a  new trial , especially for HIV-negative people who take pre-exposure medicince called PrEP for the purpose of reducing their chances of getting the virus. “It’s certainly something that people have great interest in,” Glaxo developer Bill Spreen told  Bloomberg   about the shots. “There’s going to be ...

Combining treatments for people who inject drugs is the first step towards eliminating hepatitis C

Hepatitis treatment debuts on WHO Model Essential Medicines List

Report explores the inequity in treatment access for people living with HIV and Hepatitis C co-infection in Canada

Report explores the inequity in treatment access for people living with HIV and Hepatitis C co-infection in Canada

U.S. Congress Moves Closer to Lifting Ban on Transplanting Organs From HIV-Positive Donors

Global Experts to Share HIV/AIDS Updates, Trends at July 30 Event in Washington, DC

Between July 1-July 22 2013 , Communities around the world have witnessed, heard and been devastated by incidents of brutality, horrific violence resulting in the deaths of many people because of their sexuality or because of their work among sexual minorities or marginalized communities. On July 1st and 13th in South Africa two different cases in which lesbians were bodily abused, raped and murdered was shared from various media outlets e.g., http://oblogdeeoblogda.me/2013/07/14/moving-pictures-as-slain-lesbian-laid-to-rest-amidst-controversial-memorial/ . On July 13th Dutch tourists were charged for engaging in gay propaganda.  On July 15th, the Executive Director of the Cameroonian AIDS organization CAMFAIDS Eric Lembembe Ohena was found murdered in his Yaoundé home. The grotesque experience showed marks of strangulation on his neck. His feet were broken. His face, hands, and feet had burn marks supposedly from an electric cable. This was in different media outlets e.g., htt...

                   UNRAVELLING THE MINUTAE OF VULNERABILITY IN UGANDA                   most at risk populations’ society in uganda business unusual 2011-2016                                                                          MARPS IN UGANDA ©                                                                  ...